Medifr.Be(SPRL)

BE 0885.927.130

	2023		2022		2021		2020
Profit/Loss Section 9904: Profit/Loss of the financial year (after taxes on result) (+/-)	€ -15.106	24%	€ -19.796	< -1.000%	€ 855	-81%	€ 4.522
Equity Section 10/15: Equity consists of capital, capital reserves and earnings that remain within the company. These are fully owned by the company and are at its disposal to cover its risks. The better the ratio between equity and debts, the more solvent a company is. A positive equity ratio is important. A negative equity ratio (because of accumulated losses) is a severe warning sign that the continuity of the company may be threatened.	€ -358.447	-4%	€ -343.502	-6%	€ -323.707	0%	€ -324.563
Gross margin Section 9900: Gross margin or added value is net sales minus the direct costs of the goods sold. In other words: sales invoices minus purchase invoices (70/74 – 60/61). A negative gross margin is a warning sign especially when occurring over several years. It may indicate that the company has insufficient means to cover internal costs like salaries, etc.	€ 1.388	150%	€ -2.771	-261%	€ 1.718	-71%	€ 5.888

	Date	Publication
	21-11-2007	Resignation(s) (FR)
	05-01-2007	Constitution (FR)

What is the enterprise number of Medifr.Be?

The enterprise number of Medifr.Be is BE0885927130.

When was Medifr.Be founded?

Medifr.Be was founded on 20-12-2006.

What is the address of Medifr.Be?

The current registered office of Medifr.Be is located at Avenue Coghen 165, 1180 Uccle.

When was the last time Medifr.Be filed their annual financial statements?

The most recent financial statements of Medifr.Be were filed on 08-10-2024. You can view them here.

How many employees does Medifr.Be have?

There are currently no employees working at Medifr.Be or no workforce information is available.

What is the annual turnover of Medifr.Be?

At the time of its most recent financial statements, Medifr.Be did not publish any turnover figures. Medifr.Be reported a gross margin of €1,388.05.